Geneva, June 27, 2012, 1.15 p.m.
The WIPO Global Challenges Division is holding a seminar which will address the topic of Licensing and Pricing: New Approaches in the Pharmaceutical Sector from different perspectives.
The speakers will be Dr. Chan Park, Executive Director ad interim, Medicines Patent Pool, Mr. Shailesh Pednekar, General Manager, ARV Business and Global Therapy Management, Ranbaxy Laboratories Limited, and Mr. Gregg Alton, Executive Vice President, Corporate and Medical Affairs, Gilead Sciences.
Each of these organizations has broken new ground in the field of IP licensing and pricing in the pharmaceutical sector. They will share their respective experiences.
The Seminar is open to the public interested in the subject as well as professionals working in this area. Time will be reserved for an open discussion.
Venue: WIPO Headquarters, New Building, Room NB 0.107
Date: June 27, 2012 1.15 to 2.45 p.m.